BIOS BioPlus Acquisition Corporation

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen M. Deitsch, Senior Vice President, Chief Financial Officer and Treasurer, will present at the 2018 Stephens NY Investment Conference on Wednesday, November 7, 2018 at 4:00 p.m. ET at the Lotte New York Palace Hotel.

A live webcast of BioScrip’s presentation can be accessed via the Company’s Investor Relations website at https://investors.bioscrip.com/ or through the following link: http://wsw.com/webcast/stph30/bios/.  The webcast will be archived for 90 days following the live presentation.       

About BioScrip, Inc.

BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Contacts:

Stephen Deitsch                                                                               Chief Financial Officer & Treasurer                                        T:  (720) 697-5200                                                                        stephen.deitsch@bioscrip.com                                      

Kalle Ahl, CFAThe Equity GroupT:  (212) 836-9614kahl@equityny.com